Park lab is developing computational tools for Artificial Intelligence (AI) based Drug Discovery, which is considered as one of the remaining grand challenges in computational structural biology since the emergence of AI-based structure prediction tools such as AlphaFold. We focus on developing novel deep neural networks fundamental for structure-based drug discovery, and apply it to neuromedicine discovery.